StockWatch
·
Other Consumer Services
DelistingNov 18, 2026, 05:04 PM

Medirom Receives Nasdaq Delisting Notice, Files Annual Report, Seeks Hearing

AI Summary

Medirom Healthcare Technologies Inc. received a delisting notice from Nasdaq due to its failure to file its Annual Report on Form 20-F for the year ended December 31, 2025. The company has filed the Annual Report and requested a hearing with Nasdaq to appeal the delisting determination and seek a stay of suspension pending the hearing. Separately, Medirom is also non-compliant with the minimum bid price requirement, with a deadline of April 5, 2027, to regain compliance.

Key Highlights

  • Medirom received a Nasdaq delisting notice for not filing its 2025 Annual Report on Form 20-F.
  • The company filed its 2025 Annual Report on November 18, 2026.
  • Medirom requested a hearing with Nasdaq to appeal the delisting determination.
  • A hearing request automatically stays trading suspension for 15 days; Medirom requested an extended stay.
  • The company also faces a separate minimum bid price deficiency with a compliance deadline of April 5, 2027.